PHARMACOLOGICAL IMPLICATIONS OF ADENOSINE 2A RECEPTOR- DOPAMINE TYPE 2 RECEPTOR HETEROMERIZATION

PHARMACOLOGICAL IMPLICATIONS OF ADENOSINE 2A RECEPTOR- DOPAMINE TYPE 2 RECEPTOR HETEROMERIZATION

G protein-coupled receptors (GPCRs) are heptahelical, transmembrane proteins that mediate a plethora of physiological functions by binding ligands and releasing G proteins that interact with downstream effectors. GPCRs signal as monomers, complexes of the same receptor subtype (homomers), or complex...

Full description

Bibliographic Details
Main Author:	Hatcher-Solis, Candice N
Format:	Others
Published:	VCU Scholars Compass 2016
Subjects:	G-protein coupled-receptor G protein Signaling Heteromerization Adenosine 2A Receptor Dopamine D2 Receptor Parkinson's disease Medical Sciences
Online Access:	http://scholarscompass.vcu.edu/etd/4458 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=5514&context=etd

Similar Items

Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
by: Federica Bono, et al.
Published: (2020-07-01)

Diversity and bias through receptor-receptor interactions in GPCR heteroreceptor complexes. Focus on examples from dopamine D2 receptor heteromerization
by: Kjell eFuxe, et al.
Published: (2014-05-01)

Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer
by: Dasiel O. Borroto-Escuela, et al.
Published: (2018-08-01)

Cryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein
by: Javier García-Nafría, et al.
Published: (2018-05-01)

Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function?
by: Natalia L. Rukavina Mikusic, et al.
Published: (2020-08-01)

Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases
by: Wiwin Is Effendi, et al.
Published: (2020-03-01)

Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation and function.
by: Ivone eGomes, et al.
Published: (2014-12-01)

Prolonged Amphetamine Exposures Increase the Endogenous Human Dopamine Receptors 2 at the Cellular Membrane in Cells Lacking the Dopamine Transporter
by: Vindhya Nawaratne, et al.
Published: (2021-08-01)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D<sub>2</sub> Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
by: Lakshmi Vasudevan, et al.
Published: (2019-08-01)

Human δ opioid receptor Phe27 and Cys27 variants:the role of heteromerization and pharmacological chaperones in receptor processing and trafficking
by: Leskelä, T. (Tarja)
Published: (2011)

Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
by: Dasiel O. Borroto-Escuela, et al.
Published: (2018-02-01)

Allosteric Interactions between Adenosine A<sub>2A</sub> and Dopamine D<sub>2</sub> Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging
by: Kavya Prasad, et al.
Published: (2021-02-01)

Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia
by: Francesco Napolitano, et al.
Published: (2010-06-01)

The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders
by: Dasiel O. Borroto-Escuela, et al.
Published: (2021-03-01)

Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living Cells
by: Hector E. Yarur, et al.
Published: (2020-01-01)

Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A2A receptor
by: Gemma Navarro, et al.
Published: (2020-01-01)

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
by: David Moreno-Delgado, et al.
Published: (2020-06-01)

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors
by: Jean-Martin eBeaulieu, et al.
Published: (2011-11-01)

Adenosine and Metabotropic Glutamate Receptors Are Present in Blood Serum and Exosomes from SAMP8 Mice: Modulation by Aging and Resveratrol
by: Alejandro Sánchez-Melgar, et al.
Published: (2020-07-01)

Evaluation of Substituted <i>N</i>-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands
by: Boeun Lee, et al.
Published: (2021-05-01)

Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure
by: Patricia Rueda, et al.
Published: (2021-03-01)

Adenosine A2A receptors and A2A receptor heteromers as key players in striatal function
by: Sergi eFerre, et al.
Published: (2011-06-01)

Lipid Rafts and Dopamine Receptor Signaling
by: Victor J. Martinez, et al.
Published: (2020-11-01)

Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors
by: Dasiel O. Borroto-Escuela, et al.
Published: (2018-07-01)

New perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP efflux and extracellular cAMP-adenosine pathway.
by: Rosely Oliveira Godinho, et al.
Published: (2015-03-01)

Role of beta-arrestin 2 downstream of dopamine receptors in the basal ganglia
by: Thomas eDel'Guidice, et al.
Published: (2011-09-01)

Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists
by: Flavia Varano, et al.
Published: (2020-07-01)

Voltage-Dependent Dopamine Potency at D1-Like Dopamine Receptors
by: Richard Ågren, et al.
Published: (2020-10-01)

Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia
by: X. Zhou, et al.
Published: (2017-08-01)

The Role of Adenosine Receptors in Psychostimulant Addiction
by: Inmaculada Ballesteros-Yáñez, et al.
Published: (2018-01-01)

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists
by: Daniela Catarzi, et al.
Published: (2019-10-01)

G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent
by: Mohammed Jamshad, et al.
Published: (2015-04-01)

Evolution of vertebrate GnRH receptors from the perspective of a basal vertebrate
by: Stacia A Sower, et al.
Published: (2012-11-01)

Biochemical and biophysical studies on adenosine receptors and their interaction partners
by: Nanekar, R. (Rahul)
Published: (2016)

Distinct Dopamine D<sub>2</sub> Receptor Antagonists Differentially Impact D<sub>2</sub> Receptor Oligomerization
by: Elise Wouters, et al.
Published: (2019-04-01)

Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase
by: Sergi Ferré, et al.
Published: (2018-04-01)

The Specificity of Downstream Signaling for A<sub>1</sub> and A<sub>2A</sub>R Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength
by: Abhinav R. Jain, et al.
Published: (2020-12-01)

l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
by: Yoshio Goshima, et al.
Published: (2019-10-01)

Membrane Nanoscopic Organization of D2L Dopamine Receptor Probed by Quantum Dot Tracking
by: Oleg Kovtun, et al.
Published: (2021-07-01)

A Comparison in the Use of the Crystallographic Structure of the Human A<sub>1</sub> or the A<sub>2A</sub> Adenosine Receptors as a Template for the Construction of a Homology Model of the A<sub>3</sub> Subtype
by: Enrico Margiotta, et al.
Published: (2019-02-01)

Cannot write session to /tmp/vufind_sessions/sess_r5snshnk9v0qgtnf12egiosqjc